97 related articles for article (PubMed ID: 19958453)
1. Usefulness of topical immunotherapy with squaric acid dibutylester for refractory common warts on the face and neck.
Hama N; Hatamochi A; Hayashi S; Namikawa H; Sotome A; Hamasaki Y; Yamazaki S
J Dermatol; 2009 Dec; 36(12):660-2. PubMed ID: 19958453
[No Abstract] [Full Text] [Related]
2. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.
Lee AN; Mallory SB
J Am Acad Dermatol; 1999 Oct; 41(4):595-9. PubMed ID: 10495383
[TBL] [Abstract][Full Text] [Related]
3. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].
Claudy AL; Roche H
Ann Dermatol Venereol; 1981; 108(10):765-7. PubMed ID: 7305218
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of recalcitrant warts with topical squaric acid in immunosuppressed child.
Huang W; Morrell D
Pediatr Dermatol; 2008; 25(2):275-6. PubMed ID: 18429804
[TBL] [Abstract][Full Text] [Related]
6. Topical squaric acid dibutylester therapy for alopecia areata.
Flowers FP; Slazinski L; Fenske NA; Pullara TJ
Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
[No Abstract] [Full Text] [Related]
7. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
Pigatto PD; Rapisarda R; Polenghi MM; Altomare GF
G Ital Dermatol Venereol; 1987 Dec; 122(12):667-70. PubMed ID: 3329149
[No Abstract] [Full Text] [Related]
8. Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
Kehdy J; Erickson C; Rady P; Tyring S; Gaspari AA
Cutis; 2015 Aug; 96(2):114-8. PubMed ID: 26367749
[TBL] [Abstract][Full Text] [Related]
9. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
[TBL] [Abstract][Full Text] [Related]
10. Contact immunotherapy with squaric acid dibutylester for warts [corrected].
Iijima S; Otsuka F
Dermatology; 1993; 187(2):115-8. PubMed ID: 8358098
[TBL] [Abstract][Full Text] [Related]
11. Clinical sequelae associated with squaric acid dibutylester topical sensitization.
Foley S; Blattel SA; Martin AG
Am J Contact Dermat; 1996 Jun; 7(2):104-8. PubMed ID: 8796751
[TBL] [Abstract][Full Text] [Related]
12. Change in cytokines in patients with warts after contact immunotherapy with squaric acid dibutylester.
Park HJ; Choi YW; Kim SH; Shin MS; Lee SW; Oh MK; Choi HY
Clin Exp Dermatol; 2013 Oct; 38(7):775-81. PubMed ID: 23611147
[TBL] [Abstract][Full Text] [Related]
13. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
Pardasani AG; Turner E; McMichael AJ
Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
[No Abstract] [Full Text] [Related]
14. Topical immunotherapy with contact sensitizers: a model to study the natural history of delayed hypersensitivity.
Mastrolonardo M; Lopalco PL; Diaferio A
Contact Dermatitis; 2002 Oct; 47(4):210-4. PubMed ID: 12492519
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester.
Iijima S; Otsuka F
Arch Dermatol; 1997 Apr; 133(4):539-40. PubMed ID: 9126022
[No Abstract] [Full Text] [Related]
16. Topical immunotherapy with squaric acid dibutylester: unusual hair pigmentary changes in two cases of alopecia areata.
Mastrolonardo M; Diaferio A
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):186. PubMed ID: 12046838
[No Abstract] [Full Text] [Related]
17. Topical immunotherapy in the treatment of chronic severe alopecia areata.
Shapiro J
Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
[TBL] [Abstract][Full Text] [Related]
18. Squaric acid immunotherapy for warts in children.
Silverberg NB; Lim JK; Paller AS; Mancini AJ
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):803-8. PubMed ID: 10775858
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Multiple-Resistant and/or Recurrent Cutaneous Warts With Squaric Acid Dibutylester: A Randomized, Double-blind, Vehicle-controlled Clinical Trial.
DallʼOglio F; Luca M; Barresi S; Micali G
Dermatitis; 2017; 28(5):308-312. PubMed ID: 28885314
[TBL] [Abstract][Full Text] [Related]
20. Topical immunotherapy of alopecia areata.
van der Steen PH; Happle R
Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
